Skip to content
healthcare.dev

Wynzora

NDC 73499-001, Calcipotriene and Betamethasone dipropionate, cream, from MC2 Therapeutics Ltd.

Product NDC
73499-001
Status
Listed
Labeler
MC2 Therapeutics Ltd
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213422
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73499-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CALCIPOTRIENE50 ug/g
  • BETAMETHASONE DIPROPIONATE64 mg/g

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Vitamin D Analog [EPC]; Vitamin D [CS]

Package NDCNDC-11Package
73499-001-01734990001011 TUBE in 1 CARTON (73499-001-01) / 60 g in 1 TUBE
73499-001-037349900010310 TUBE in 1 CARTON (73499-001-03) / 5 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/36c5c818-0d40-445e-a3c0-0f46723a25e2

Use it

Look up 73499-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73499-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73499-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.